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ANTITRIPANOSOM OLEH METABOLIT SEKUNDER DARIPADA 
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NEGARA PULAU PINANG 
 
ABSTRAK 
 
Ekosistem Malaysia yang unik menjadikannya sebagai sumber alam yang berpotensi 
untuk memencilkan pencilan aktinomiset yang dapat menghasilkan bioaktif 
metabolit sekunder yang menarik. Pelbagai bioaktiviti dapat ditunjukkan oleh 
metabolit sekunder ini termasuk aktiviti antitripanosom. Penghasilan sebatian pemula 
yang baharu diperlukan dalam rawatan penyakit ini yang disebabkan oleh parasit 
trypanosoma, memandangkan ubat yang digunakan pada ketika ini adalah sangat 
terhad disebabkan rintangan ubat terhadap penyakit tersebut. Dalam kajian ini, 
sejumlah 83 pencilan aktinomiset telah berjaya dihidupkan semula daripada Koleksi 
Kultur Aktinomiset FRIM (FACC) yang disimpan didalam tiub krio pada suhu -
80
o
C. Kesemua pencilan aktinomiset ditumbuhkan di dalam tiga media fermentasi 
(M1, M2, dan M3) dan sejumlah 249 ekstrak telah dihasilkan untuk diuji pada asai 
antitripanosom secara in vitro terhadap parasit Trypanosoma brucei brucei strain 
BS221 melalui asai pertama, kedua dan ketiga. Ekstrak yang menunjukkan aktiviti 
kuat dan sederhana seterusnya dinilai terhadap aktiviti antitripanosom melalui asai 
ketiga dan ujian sitotoksisiti untuk menentukan indeks selektif (SI) ekstrak tersebut. 
Antara ekstrak aktif yang menunjukkan nilai selektif yang bagus terhadap parasit 
trypanosoma, empat ekstrak iaitu FACC-A032-M3, FACC-A026-M3, FACC-A048-
M3 dan FACC-A049-M3 menghasilkan aktiviti antitripanosom yang kuat (IC50 < 
1.56 g/ml) serta indeks selektif yang tinggi (SI  20). Kajian seterusnya dijalankan 
kepada pencilan yang berpotensi ini dengan membuat pemerhatian ke atas kultur, 
 xviii 
makromorfologi, ciri-ciri fisiologi dan biokimia serta jenis rantaian spora. Pencilan 
FACC-A032 dan FACC-A026 dikenalpasti menyerupai Streptomyces sp. dan 
pencilan FACC-A048 dan FACC-A049 dikategorikan dalam kumpulan bukan 
Streptomyces. Kajian seterusnya melalui analisis terhadap isomer diaminopimelic 
acid (DAP) bagi hydrolysates keseluruhan sel mengesahkan bahawa pencilan FACC-
A032 dan FACC-A026 yang mengandungi isomer LL-DAP sebagai spesis dari 
kepunyaan genus Streptomyces. Manakala, pencilan FACC-A048 dan FACC-A049 
yang mengandungi isomer meso-DAP telah dikenalpasti kepunyaan genera bukan 
Streptomyces. Kajian terhadap profil pertumbuhan pencilan FACC-A032 dan FACC-
A049 di dalam media M3 menunjukkan aktiviti antitripanosom maksimum oleh 
ekstrak kultur dicapai selepas lapan hari fermentasi pada keadaan 28 ± 2
o
C dan 200 
rpm. Pencilan FACC-A026 dan FACC-A048 di dalam media M3 menunjukkan 
aktiviti maksimum selepas hari ketujuh pada keadaan yang sama. Daripada empat 
pencilan yang dipilih, hanya pencilan FACC-A032 masih menunjukkan aktiviti kuat 
(IC50 < 1.56 g/ml) semasa penghasilan ekstrak menggunakan fermentasi kelalang 
goncang (1L). Pemencilan berpandukan bioasai terhadap ekstrak daripada 
Streptomyces sp. FACC-A032 menghasilkan dua kolum fraksi yang aktif (2Sn-
A032-M3-F8 dan My-A032-M3-F5). Berdasarkan maklumat yang diperolehi dari 
kajian terdahulu, puncak spektrum UV-nampak yang dikenalpasti pada dua fraksi 
aktif ini mempunyai ciri UV-nampak yang sama dengan sebatian staurosporine. Ini 
menunjukkan bahawa kehadiran sebatian yang berkemungkinan seperti staurosporine 
menyumbang kepada aktiviti antitripanosom yang kuat pada pencilan FACC-A032. 
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ANTITRYPANOSOMAL SECONDARY METABOLITES FROM SOIL 
ACTINOMYCETES ISOLATED FROM PENANG NATIONAL PARK 
 
ABSTRACT 
 
 The unique ecosystems in Malaysia can be utilized as potential sources for 
isolating actinomycetes isolates that produce interesting bioactive secondary 
metabolites. This secondary metabolite exhibits a wide range of bioactivity including 
antitrypanosomal activity. The option of new lead compound is needed for the 
disease treatment that caused by the trypanosome parasite since the existing drugs to 
cure are very limited due to drug resistance. In this study, a total of 83 actinomycetes 
isolates were successfully revived from cryovials stored at -80
o
C in FRIM 
Actinomycetes Culture Collection (FACC). The isolates were grown in three 
different fermentation media (M1, M2, and M3) and a total of 249 culture broth 
extracts obtained were evaluated for in vitro antitrypanosomal assay against 
Trypanosoma brucei brucei strain BS221 via primary, secondary and tertiary assays. 
Extracts that showed strong and moderate activities were evaluated for 
antitrypanosomal activity in tertiary assay and cytotoxicity to determine their 
selectivity index (SI) values. Among the active extracts that showed good selectivity 
toward the trypanosoma parasite, four extracts FACC-A032-M3, FACC-A026-M3, 
FACC-A048-M3 and FACC-A049-M3 produced strong antitrypanosomal activity 
(IC50 value < 1.56 g/ml) and high selectivity (SI  20). The potential isolates were 
further studied for their cultural, macromorphological, physiological and biochemical 
characteristics and spore chain type. Isolates FACC-A032 and FACC-A026 were 
tentatively identified as Streptomyces sp. and isolates FACC-A048 and FACC-A049 
were categorized into the non-Streptomyces group. Analysis of diaminopimelic acid 
 xx 
(DAP) isomer of whole-cell hydrolysates further confirmed the isolates FACC-A032 
and FACC-A026 that contained LL-DAP isomer as species belonging to the genus 
Streptomyces. Whereas, isolates FACC-A048 and FACC-A049 that possess the 
meso-DAP isomer were confirmed to belong to non-Streptomyces genera. Growth 
profile study of isolates FACC-A032 and FACC-A049 in medium M3 showed that 
maximum antitrypanosomal activity in culture extracts was achieved after eight days 
of fermentation at 28 ± 2
o
C and 200 rpm. Isolates FACC-A026 and FACC-A048 in 
medium M3 showed a maximum activity after seven days of fermentation under the 
same conditions. Among the four selected isolates, it was observed that only isolate 
FACC-A032 maintained a strong activity (IC50 value < 1.56 g/ml) in extracts 
produced using 1L flask fermentation conditions. Bioassay-guided isolation of crude 
extract from Streptomyces sp. FACC-A032 afforded two active column fractions 
(2Sn-A032-M3-F8 and My-A032-M3-F5). Based on information from the literature, 
the UV visible spectra of two peaks identified in the active fractions were identical 
and they matched with UV-vis characteristics of the compound staurosporine. This 
indicates the possible presence of staurosporine-like compounds which contributed to 
the strong antitrypanosomal activity in isolate FACC-A032.  
 1 
CHAPTER 1 
 
INTRODUCTION 
 
1.0  Introduction of the study 
 
Human African Trypanosomiasis (HAT), also known as sleeping sickness in 
humans and nagana in cattle is caused by protozoan parasites of the genus 
Trypanosoma. HAT disease still remains as a serious health problem to human and 
farm animals on the WHO list of neglected tropical diseases and a major problem to 
the poorer countries in the world especially throughout sub-Saharan Africa (WHO 
2010). Even though HAT is an endemic disease, the growth in an international travel 
and immigration which is currently taking place is a well-known phenomenon, 
therefore HAT is no longer geographically-restricted as both immigrants and 
travelers in the western world may be present with these infections (Norman et al., 
2010). Chemotherapy, together with the vector control, remains one of the most 
important elements in the control of trypanosomatid disease as at the moment, there 
are no vaccines to prevent the trypanosome infection. Several drugs such as suramin, 
pentamidine, melarsoprol and eflornithine were currently registered to treat the 
disease. However, these drugs are limited and all the current treatment suffers from 
significant drawbacks (Abdel Sattar et al., 2009). Thus, there is an urgent need for 
more effective and safer trypanocidal drugs to treat sleeping sickness. 
 
Trypanosome parasites (Trypanosoma brucei) transmitted by tsetse fly vector 
(Glossina spp.) to human can also infects animals. Trypanosomes are transmitted by 
 2 
the bloodsucking male and female tsetse flies from one mammalian host to another 
(Salem et al., 2006). The transmission to human is caused by the injection of 
metacyclic trypanosomes in saliva of the tsetse fly. After the bite of trypanosome-
infected tsetse fly, the life cycle of T. brucei subspecies begun with metacyclic forms 
differentiate into the bloodstream, subcutaneous tissues and lymph. In some but not 
all infections, a skin reaction occurs at the site of inoculation, which is caused by a 
local inflammatory response to the parasites (Sternberg, 2004). Following the first 
stage, the disease develops rapidly into a second stage when parasites cross the 
blood-brain barrier, invading the central nervous system. 
 
Actinomycetes are a group of morphologically diverse gram-positive 
bacteria. The growth of actinomycetes is made up of branching filament, producing 
mycelium that may be of two kinds, substrate mycelium and aerial mycelium. 
Actinomycetes can be isolated from soil and marine sediments. Soil, in particular is 
an intensively exploited ecological niche for isolation of actinomycetes that produce 
many useful biologically active natural products, including clinically important 
antibiotics. A large collection of actinomycetes isolated from various locations 
throughout Peninsula Malaysia has been maintained in FRIM Actinomycetes Culture 
Collection (FACC). Besides preparing stock cultures for various research activities, 
the FACC also maintains a database containing information on the location of soil 
collection, name of collector, morphological and taxonomical characteristics and 
biochemical and gene typing profiles of the isolates were also documented (Getha et 
al., 2007).  
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  Natural product compounds could be derived from either primary or 
secondary metabolism of living organisms where the primary such as 
polysaccharides, nucleic and fatty acid are common in all biological system. 
However, the secondary metabolites are chemically and taxonomically extreme 
diverse compounds with indistinguishable function (Berdy, 2005). The secondary 
metabolites are important part of natural products where it usually exhibits some 
kind of biological activities or bioactivity such as antibacterial, antifungal, 
antiparasitic, antiviral, anti-inflammatory, anticancer and others. Secondary 
metabolites are synthesized by the pathways which are often connected and 
influenced by primary metabolism. The concept of secondary metabolites include 
products of overflow metabolism because of nutrient limitation, force of metabolism 
produced during idiophase or defense mechanism regulator molecules (Sarker et al., 
2006). The composition of the culture medium in actinomycetes growth influenced 
the biosynthesis of the bioactive molecules (Tortora et al., 2001). Hence by using a 
different type of culture medium, it is assumed that different bioactive molecules will 
be produced from the actinomycetes isolates. These active molecules are generally 
extracellular and their isolation in a highest purity from the complex fermentation 
broth needs the application of a combination of various separation steps (Raoudha et 
al., 2006). 
 
Studies have shown that the unique ecosystem in Malaysia can be potential 
source for isolating bioactive secondary metabolite from actinomycetes (Getha et al., 
2008) and previous study also discovered that metabolites from soil microorganisms 
has potential antitrypanosomal activity in vitro (Otoguro et al., 2008). Therefore, in 
the present study, actinomycetes isolated from Malaysian soil in the FACC 
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collections are studied for activity against the trypanosome parasite Trypanosoma 
brucei brucei strain BS221 and bioassay-guided studies are conducted to isolate the 
active fraction/s from the active extract/s. The optimized antitrypanosomal assay 
methods provided by Kitasato Institute, Japan was used in this study (Otoguro et al., 
2008). However, the strain of test organism which is T. b. brucei used in the current 
study differs from that used by Otoguro et al. (2008). Kitasato Institute used the T. b. 
brucei strain GUTat 3.1 while the T. b. brucei strain BS221 was used in this study. 
Therefore, the inoculum size of test organism needs to improvise before screening a 
total of 249 actinomycetes extracts for in vitro antitrypanosomal activity. The 
potential isolate/s with strong antitrypanosomal activity will be characterized based 
on their morphological, physiological and biochemical characteristics. Bioassay-
guided fractionation of the culture extracts from potential isolate/s will lead to the 
isolation of active fraction/s. During the bioassay-guided fractionation, the process of 
fractionation of actinomycetes extract/s and biological testing of the fraction/s is 
repeated until the active fraction/s is obtained (Rimando et al., 2001). Followed by 
high performance liquid chromatography (HPLC) analysis of the active fraction/s to 
get their chemical profile.  
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1.1  Objectives 
 
The objectives of the study are: 
 
i. To optimize the inoculum size of Trypanosoma brucei brucei in the in vitro 
antitrypanosomal assay to test crude extracts from actinomycetes. 
 
ii. To characterize the potential actinomycetes that produce extracts with high 
antitrypanosomal activity. 
 
iii. To determine the optimum fermentation period for maximum 
antitrypanosomal metabolites productions to carry out bioassay-guided 
isolation of active fraction/s from the potential extract. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
 
2.1 General overview of actinomycetes 
 
One particular family of microbe that grabs the attention of scientists was 
actinomycetes. Some scientists considered the actinomycetes as bacteria while others 
categorized them as fungi because they have filamentous form. Actinomycetes are 
intermediate in character between bacteria and fungi as they share some properties 
with true bacteria and some with fungi. Finally, research investigation has considered 
the actinomycetes as prokaryotic organism because they have a cell wall structure 
characteristic of bacteria (Goodfellow and Williams, 1986). 
 
According to National Center for Biotechnology Information (NCBI) on 
taxonomy browser, actinomycetes and actinobacteria are synonyms. Actinomycetes 
are Gram-positive filamentous bacteria with high DNA guanine-plus-cytosine (G+C) 
contents. They belong to the order Actinomycetales (Superkingdom: Bacteria, 
Phylum: Firmicutes, Class: Actinomycetes, Subclass: Actinobacteridae), sub-order of 
Actinomycineae and family of Actinomycetaceae (Schaal et al., 2006). Some 
actinomycetes form a branching filament and produce mycelium. The mycelium can 
be a substrate or both substrate and aerial. Actinomycetes are also a group of 
physiologically diverse bacteria where the diversity can be seen in the production of 
extracellular enzymes and in the thousands kinds of metabolic products which they 
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synthesize and excrete (Ensign, 1992). Most of these products are antibiotics with the 
ability to inhibit growth of other bacteria, fungi, viruses and protozoa. 
 
Actinomycetes are widely distributed in various habitats including soil, water, 
marine sediment, plant and extreme environment such as desert region, antarctic soil, 
hot spring and highly saline area (Sharma et al., 2012). However, the largest 
population of actinomycetes have come from soil (Iwai and Takahashi, 1992). In 
natural soil habitats the genus Streptomyces is common and usually a major 
component of the total actinomycetes population (Hayakawa, 2008). Isolation of 
actinomycetes from soils of a tropical rainforest has been reported by Xu et al. 
(1996); Lo et al. (2002); Thakur et al. (2007) and Van et al. (2011). In each of the 
study, Streptomyces was found to be the most abundant genus isolated, followed by 
non-Streptomyces. Besides that, in Malaysia, the Streptomyces genus was also found 
to be the major group of actinomycetes isolated from soil samples collected from 
coastal mangrove areas (Getha et al., 2004) and from around roots of medicinal and 
forest plant species (Getha et al., 2008). Actinomycetes collected from Penang 
National Park were generally grouped into the following genera: Streptomyces 
(33.3% of total isolates), Micromonospora (11.8%), Actinoplanes (2.9%), 
Nocardioform (10.8%). About 27.5% of the isolates were grouped as oligosporic-
type. Isolates that do not fall under these groups were categorized as others (Getha et 
al., 2008).  
 
A numbers of studies have shown that the unique ecosystem in Malaysia can 
be a potential source for isolating bioactive actinomycetes. Vikineswary et al. (1997) 
reported on the isolation and screening for antifungal activity of indigenous 
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actinomycetes from the mangrove stands of Morib, Selangor. Among the selected 
strains, 33% exhibited antifungal activity against all the fungi tested. They concluded 
that actinomycetes isolates from the tropical mangrove mud might be a potential 
source for the discovery of antifungal compounds. Ismet et al. (2002) reported on the 
diversity of Micromonospora spp. in Malaysian mangrove rhizosphere soil. Seventy 
putative Micromonospora isolates were selected and assigned to twelve single and 
multi-membered colour group based on their colony colour and spore morphology. 
However the data were not sufficient for the accurate identification of the species. 
Further taxonomic characterization, especially data on the molecular systematic is 
essential for species identification.  
 
 Getha and Vikineswary (2002) reported on an antagonistic effect of 
Streptomyces violaceusniger strain g10 isolated from a coastal sand bar on Fusarium 
oxysporum f.sp. cubense race 4. Inhibition zones in “cross-plug” assay plates 
demonstrated the evidence for in vitro antibiosis of strain g10. An indirect method 
also showed that the strain produced diffusible metabolites which have inhibitory 
effects on the growth of F. oxysporum f. sp.cubense race 4 in a soil environment. 
Their study suggested the potential of developing strain g10 as a biocontrol agent for 
Fusarium wilt disease of banana. Subsequent studies on mangrove actinomycetes 
focused on their antimicrobial activity against pathogenic bateria and fungi 
(Vikineswary et al., 1997; Vikineswary et al., 1998; Kavithambigai et al., 2001).  
 
Isolation of marine actinomycetes was reported by Tan et al. (2005) in which 
non-Streptomyces strains from bryozoan or aquatic organisms and marine sponges of 
Langkawi island, Malaysia were isolated. This study showed that the marine 
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organisms hold relatively high diversity of non-Streptomyces isolates that could be 
potential producers of novel bioactive compounds. Broad distribution of 
actinomycetes from the genera Micromonospora, Nocardia, or Streptomyces from 
marine sources was identified by Goodfellow and Haynes (1984). Kumar et al. 
(2011) screened marine actinobacteria for antimicrobial compounds. A total of 78 
isolates were obtained from marine sediments of Bengal bay where Streptomyces is 
the predominant genus. Twenty eight percent of the isolates exhibited antibacterial 
activity and others exhibited both antibacterial and antifungal activity.  
 
Apart from the forest soil and marine habitats, actinomycetes have been 
isolated from other unusual habitats with extreme environment. Li et al. (2005) 
isolated alkaliphilic actinomycetes, strain YIM 80305 from a muddy sample in 
Chaka salt lake. In the study, optimum pH for growth of the strain was 9.0 to 10.0 
with a limited growth at pH 7.0 and the strain was assigned to the genus 
Streptomyces. Another alkaliphilic actinomycetes belonging to a new genus and 
species, Borgoriella caseilytica was obtained from a soda soil sample. This strain has 
the characteristics of not acid fast, halotolerant and optimal growth occurs at pH 
values between 9.0 and 10.0 (Groth et al., 1997). According to Yumoto et al. (2011) 
alkaliphilic bacteria can be defined as a bacteria that can grow at above or at pH 10.0 
or grow equally better at pH 9.0. Acidophilic actinomycetes have been isolated from 
acidic forest soils and lowland peaty soil. It was found that acidophilic actinomycetes 
were present in soils whose actual pH does not exceed 6.8. This study concluded that 
all soil actinomycetes that are isolated through media with acidic pH are able to grow 
at pH 5.0 or lower can be considered to be acidophilic (Zakalyukina et al., 2002). 
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 Thermophilic Streptomyces can be grown between 28
o
C and 55
o
C 
(Goodfellow et al., 1987). According to Tendler and Burkholder (1961) thermophilic 
actinomycetes can be divided into two genera which are Streptomyces and 
Thermoactinomyces. Results on temperature limits of the thermophilic actinomycetes 
showed that organisms that grow to fairly narrow ranges of high temperature (65 to 
67
o
C) belong to the genus Thermoactinomyces and only a few Streptomyces isolates 
can grow at temperature above 60
o
C. Studies on a cluster analysis of Streptomyces 
from extreme environments suggested that the thermophilic (growth at 65
o
C), 
psychrophilic growth at 0
o
C; optimum growth at 10 to 15
o
C; no growth at 28
o
C, 
acidophilic (optimum growth at pH3.0 to 4.0) and alkalophilic (optimum growth at 
pH10.0) strains should be regarded as an independent species-group (Jiang et al., 
1989).  
 
It is believed that one efficient way of discovering novel bioactive 
metabolites is through isolation of novel microorganisms from new niche habitats. 
Thus, the isolation of new actinomycetes strains for screening of bioactive 
compounds from the desert soils at Mojave Desert, California was investigated by 
Takahashi and Omura (2003). In this study, the optimum temperature for growth of 
actinomycetes isolated from the desert soil was higher than the actinomycetes 
isolated from the temperate zone. This can be logically understood with the 
relationship of the high temperature and dryness of the desert environment. Bioactive 
compound were also discovered from actinomycetes isolated from extreme 
environments such as Antartic (Spring et al., 2003). 
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Actinomycetes within healthy plants have also been widely reported. 
Endophytic microorganisms include bacteria, actinomycetes and fungi that live in the 
tissue of living plants (Hasegawa et al., 2006). There are about 300,000 plant species 
on earth and each plant is a host to at least one endophytic microorganism (Strobel 
and Daisy, 2003). Endophytic actinomycetes from tropical plants were reported to be 
widespread in roots and uncommon in leaves (Janso and Carter, 2010). In their study, 
57% of the isolates obtained were identified as Streptomyces sp. and the remaining as 
Nocardioides, Kitasatosporia, Pseudonocardia, Actinomadura and 
Kibdelosporangium. Priya (2012) found that endophytic Streptomyces sp. were 
prolific producers of fungal inhibitory bioactive compounds.  
 
2.2 Characterization of actinomycetes 
 
A polyphasic taxonomic approach involving phenotypic and phylogenetic 
analysis is adopted in classification and description of actinomycetess. Phenotypic 
characterization of actinomycetes includes morphological (aerial mass/surface 
colour, reverse side colour of culture, soluble pigment appearance and structure of 
spore chain), physiological, and biochemical characterization. While phylogenetic 
analysis is derived from molecular methods such as 16S rRNA sequencing and DNA 
hybridization (Vandamme et al., 1996). According to Goodfellow and Haynes 
(1984), a combination of macromorphological, biochemical and spore characteristics 
can be used for identification of many genera.  
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2.2.1 Morphological characteristics 
 
The morphological characteristics of actinomycetes are useful in 
identification of Streptomyces spp. as described by Nonomura (1974) and Buchanan 
and Gibbons (1974).These characteristics are useful in routine identification for 
taxonomy of actinomycetes for many years. Mature cultures on growth media such 
as yeast extract-malt extract agar (ISP2), oatmeal agar (ISP3) and inorganic salts-
starch agar (ISP4) (Shirling and Gottlieb, 1966) with heavy spore mass are visually 
examined to determine aerial spore mass colour, substrate mycelium pigmentation 
and colour of diffusible pigments or other melanoid pigments (Shirling and Gottlieb, 
1966; Williams et al., 1969). According to Korn-Wendisch and Kutzner (1992) 
morphological criteria such as spore-chain type and spore surface ornamentation are 
useful for characterization of actinomycetes. 
  
2.2.1.1 Grouping into colour series  
 
The spore mass colour groups were initially developed for the grouping of 
Streptomyces spp. because observation by naked eyes is subjective and prone to 
human error (Tresner and Backus, 1963). Cultures without aerial mycelium/ non-
sporulating aerial mycelium (degenerate strains) are not evaluated using this colour 
system. Nevertherless, to a certain extent, colour grouping has allowed preliminary 
differentiation into smaller, manageable groups for further tests when handling a 
large number of different isolates.  
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2.2.1.2 Micromorphological characteristics 
 
The spore chain formation and spore bearing-hyphae can be described only 
with mature cultures and should be determined by using direct microscopic 
examination of the culture surface (Shirling and Gottlieb, 1966). As the colony 
become mature, characteristics of aerial filaments known as sporophores are formed. 
The Streptomyces spore called conidia is produced simply by the formation of cross-
walls in the multinucleate sporophores followed by separation of the individual cells 
directly into spores (Figure 2.1). According to Korn-Wendisch and Kutzner (1992) 
characterization of Streptomyces should involve light and electron microscopy 
because the structure of arthrospores which is one of the taxonomic properties for 
species identification can only be determined by electron microscopy. In this study, 
with direct microscopic observation using long working distance lens and adjustment 
of 300x magnification, the presence or absence of spore chains can be established to 
observe the nature of sporophores and grouped into different category of 
“morphological section” based on different sporebearing structures (Figure 2.2). 
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Figure 2.1: Diagram of stages in the conversion of a Streptomyces aerial hypha 
(sporophores) into spores (conidia) (Madigan et al., 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Morphological sections of Streptomyces based on various types of 
sporebearing structures (Madigan et al., 2000). 
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2.2.2 Physiological characteristics 
 
 To provide a more reliable characterization of the actinomycetes, a number of 
useful physiological tests have been utilized that includes the determination of 
temperature range for growth, pH, utilization of carbohydrate and a similar 
compounds as a carbon source, formation of melanin, utilization of organic acids, use 
of nitrogen sources, reduction of nitrate to nitrite, hydrolysis of urea (Korn-Wendisch 
and Kutzner 1992). Williams et al. (1983) had reported that the type of substrate 
utilized and susceptibility of the isolates to different antibiotics are useful 
physiological tests in the identification of actinomycetes. As reported by Kavitha and 
Vijayalakshmi (2007), Streptomyces rochei exhibited sensitivity to a number of 
antibiotics such as amikacin, bacitracin, ciprofloxacin, clindamycin, erythromycin, 
furoxone, gentamicin, kanamycin, metronidazole, neomycin, oxytetracycline, 
penicillin-G, polymycin-B, roxithromycin, streptomycin, tetracycline and 
vancomycin. However, this strain was resistant to ampicilin, deoxycycline 
hydrochloride, methicillin, nalidixic acid, rifampicin and trimethoprim. Based on this 
physiological characteristic, the strain was identified as Streptomyces rochei.  
 
 Other physiological criterion tested is temperature range where optimal 
growth of the isolate is obtained. Actinomycetes which can grow at low temperatures 
up to -10
o
C are called psychrophiles. Mesophilic actinomycetes can grow at medium 
temperature between 20-45
o
C and thermophilic actinomycetes at temperature above 
45
o
C. Formation of aerial mycelium is observed at appropriate time intervals which 
are 5, 10 and 15 days for mesophilic and 2, 5 and 10 days for thermophilic 
actinomycetes (Korn-Wendisch and Kutzner, 1992).  
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Other physiological characteristics of actinomycetes studied are NaCl 
tolerance and pH tolerence. The optimum pH range for growth of actinomycetes is 
in the range of 6.5 to 8.0. In acidic soils with pH less then 5.0, actinomycetes are 
almost non-existence. The usefulness of NaCl tolerance as a taxonomic aid for 
Streptomyces has been reported (Tresner et al., 1968). Tolerance up to 13% NaCl 
was observed in the study. Relationship of NaCl tolerance to various taxonomic 
features of the test strains was also established. Halo-tolerance test on multiple 
strains of every species examined in the study showed that in most cases, the 
responses from strain to strain within each species were uniform. According to 
Remya and Vijayakumar (2008), the physiological characteristics of actinomycetes 
varied depending on the available nutrients in the medium and the physical 
conditions. 
 
2.2.3 Biochemical characteristics 
 
Actinomycetes contain 2,6-diaminopemelic acid (DAP) in the cell wall 
peptidoglycans and the amino acid has three stereoisomers (LL-, DD-, and meso-
DAP) (Takahashi et al., 1989). Generally, actinomycetes strains contain either LL- or 
meso-DAP. However, Kitasatospora spp. contain both LL- and meso-DAP (Omura et 
al., 1981). Most of the DAP contained in aerial mycelium of this genus is LL-isomer 
while meso-DAP is found mainly in a substrate mycelium. Major amounts of meso-
DAP and a small amounts of both LL- and DD-DAP were also detected in the cell 
wall of some Micromonospora spp. (Hoare and Work, 1957).  
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The possible application of cell-wall DAP analysis in actinomycetes 
taxanomy was demonstrated by Cummins and Harris (1956), who also reported that 
cell wall composition is a stable character, unaffected by cultural factors such as 
medium and growth conditions. Diaminopemelic acid (DAP) analysis was used 
successfully to differentiate between non-Streptomyces (contains meso-DAP) and 
Streptomyces (contain LL-DAP) strains, including strains with morphology 
intermediete between the two genera and morphological variants of the same strain 
(Becker et al., 1964). Subsequently, Becker et al. (1965) classified various 
actinomycetes genera into four cell wall types based on their cell-wall DAP and sugar 
components. Variant strains of the four cell wall groups with different morphology 
from the parent were found to have no major changes in their cell wall constituents, 
thus confirming the stable characteristics of cell wall composition is useful in the 
classification of actinomycetess (Suput et al., 1967). However, Hasegawa et al. (1983) 
conducted an improved method from Becker et al. (1965) which is more simple, rapid 
and accurate method for grouping of actinomycetes. In this method, colony of each 
culture was harvested at a moderate growth phase and used as a whole cell sample 
hydrolysates. Samples and standard (containing LL- and meso- DAP) were spotted on 
a same thin cellulose sheet. Separation of DAP isomers from sample hydrolysates by 
thin-layer chromatography were compared with standard to determine whether LL- or 
meso- DAP occurred in the sample.  
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2.3 Secondary metabolites from actinomycetes 
 
Natural product compounds are derived either by primary or secondary 
metabolism in living organisms. The primary metabolites are common in all 
biological system while the secondary metabolites are a group of diverse compounds 
with unclear functions or activities (Berdy, 2005). In general, secondary metabolites 
can be described as compounds that are synthesized by organisms that are not strictly 
necessary for the survival of the organism. The concepts of secondary metabolism 
include products from excess metabolism as a result of nutrient limitation, thus force 
the production of bioactive secondary metabolites (Sarker et al., 2006). Antibiotics 
are secondary metabolites isolated from microbes and exhibit a wide range of 
bioactivity (Berdy, 2005). Most antibiotics are excreted when the producing 
microbes are grown in rich media. The ability of microorganisms to produce diverse 
and selective bioactive agents through secondary metabolism may lead to the 
discovery of useful compounds (Araragi, 1979).  
 
Among the bacteria, actinomycetes have proved to be a particularly rich 
source of antibiotics (Goodfellow and Williams, 1986). Actinomycetes are well 
known as secondary metabolite producers and also a group of physiologically diverse 
bacteria. This diversity is seen both in the production of extracellular enzymes and 
secondary metabolic products that they synthesize and excrete. Many of these 
products are antibiotics and have a high pharmacological and commercial interest. 
Most of them showed antibacterial, antifungal, antiviral, anticancer, herbicidal, 
insecticidal and antiparasitic activities (Kazuro and Satoshi, 2004).  Out of 10,000 
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bioactive compounds produced by actinomycetes, 76% are derived from the genus 
Streptomyces (Berdy, 2005).  
 
The genus Streptomyces is the most noteworthy producers of bioactive 
compound.  It is a prolific producer of structurally diverse bioactive metabolites and 
has yielded some of the most important products in the drug industry including 
erythromycin, kanamycin, tetracyclines, gentamicin and other classess of antibiotics. 
They have provided over two-thirds of the naturally occurring antibiotics discovered 
and continue to be a major source of novel and useful compounds (Berdy, 2005). A 
large number of Streptomyces spp. have been isolated from soil and screened for 
various bioactivities in the past (Watve et al., 2001). Table 2.1 shows some of the 
metabolites produced by soil actinomycetes and their activities. 
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Table 2.1: Actinomycetes isolated from soil and their secondary metabolites 
 
Species Metabolites Activity References 
Saccharopolyspora 
erythrae 
Erythromycin - Antibacterial 
- Respiratory 
infectious diseases 
El-Enshasy 
et al.,  
2008. 
Streptomyces 
kanamyceticus 12-6 
Kanamycin - Antibacterial 
- Anti-infectives 
Murakami 
et al., 2011. 
Streptomyces 
flavoviridis 
Zorbamycin - Antitumor Wang et 
al., 2007. 
Streptomyces 
hygroscopicus 
Himastatin - Antitumor Leet et al., 
1995. 
Streptomyces 
rimosus 
Oxytetracycline - Antibacterial Hansen et 
al., 2001. 
Streptomyces 
nodosus 
Amphotericin B - Antifungal 
- Antileishmania 
Caffrey et 
al., 2001. 
Streptomyces 
venezuelae 
Chloramphenicol - Antibacterial He et al., 
2001. 
Streptomyces sp. Vinylamycin - Antibacterial Igarashi et 
al., 1999. 
Streptomyces 
nanchangensis 
Meilingmycin - Antiparasitic Sun et al., 
2002. 
Streptomyces 
tendae 
Nikkomycins - Antifungal Decker et 
al., 1989. 
Nocardia sp Tubelactomicin - Antibacterial Igarashi et 
al., 2000. 
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Nocardia lurida Benzanthrins A 
and B 
- Antibacterial Theriault et 
al., 1986 
Streptomyces 
nogalater 
Nogalamycin - Antitumor Ylihonko et 
al., 1996. 
Streptomyces 
rochei 
Lankamycin - Antibacterial Suzuki et 
al., 2010. 
Streptomyces 
platensis 
Resormycin - Herbicidal 
- Antifungal 
Igarashi et 
al., 1997. 
Streptomyces 
lavendulae 
Ileumycin - Antifungal Kawakami 
et al., 1978. 
Streptomyces 
lavendulae 
Mitomycin C - Antitumor Sheldon et 
al., 1999. 
Micromonospora 
neihuensis 
Neihumicin - Cytotoxic 
 
Wu et al., 
1988. 
Streptomyces 
niveus 
Novobiocin - Antibacterial Kominek, 
1972. 
Streptomyces sp. 
HP 530 
Saptomycins - Antitumor Abe et al., 
1993. 
Streptomyces 
lavendulae 
Lavendamycin - Antitumor Balitz et 
al., 1982. 
Streptomyces 
microflavus 
Fattiviracin A1  - Antiviral Uyeda et 
al., 1998. 
Actinomadura 
verrucosospora 
Verucopeptin - Antitumor Nishiyama 
et al., 1993. 
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2.4 Human African Trypanosomiasis  
 
 Human African trypanosomiasis (HAT) or sleeping sickness is caused by the 
protozoan parasites Trypanosoma brucei infection. This disease is endemic in Africa 
and caused by two subspecies of Trypanosoma brucei which are Trypanosoma 
brucei rhodosiense and Trypanosoma brucei gambiense. T. b. rhodosiense causes 
more serious health risk in eastern and southern Africa and T. b. gambiense causes a 
major public health problem over a huge areas of western and central African (Fevre 
et al., 2006). Other subspecies of T. brucei, which usually infects domestic and wild 
animals, are known as African animal trypanosomiasis or nagana disease. This 
disease does not infect humans and is caused by non-human pathogenic trypanosome 
species such as T. b. brucei, T. congolense and T. evansi (Steverding, 2008). 
However, there are several reports of HAT appearing in human which were caused 
by non-human pathogenic trypanosome species (Brun et al., 2010). Molecular 
analysis of blood samples taken from a 10-month old Ghanaian boy recovered from a 
T. brucei infection indicated that the parasites belonged to the T. b. brucei species 
which is normally non-infectious to human (Deborggraeve et al., 2008). In another 
study, Joshi et al. (2005) reported of a human infection by T. evansi, the causative 
agent of animal trypanosomiasis. There was also a report of a woman patient in Cote 
d’Ivoire who had mixed infection of T. brucei and T. congolense after the 
trypanosomes were analysed using DNA identification. The patient was treated 
successfully with pentamidine and her general health improved within two weeks 
(Truc et al., 1998).  Based on the cases that have been reported, Deborggraeve et al. 
(2008) suggested that in a non-endemic region, HAT-suspected cases should be 
critically diagnosed and managed because misdiagnosis of non-HAT cases increase 
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the unnecessary administration of toxic HAT drugs and the consequent discomfort 
and risks. 
  
Trypanosomes are transmitted by the bloodsucking male and female tsetse 
flies of the genus Glossina sp. (Figure 2.3) from one mammalian host to another 
(Salem et al., 2006). As reported by Brun et al. (2010), HAT transmission occurs in 
children and adults during activities such as farming, hunting, fishing or washing 
cloth. Trypanosoma parasites were first detected in the blood at four to 10 days after 
infection, showing that migration of parasites from the site of fly bite was very rapid. 
This will cause anaemia as a key feature of the disease, with a reduction in the 
numbers and average size of red blood cells and associated decline in numbers of 
platelets and white blood cells (John et al., 2008). The late stage of infection starts 
when the parasite cross the blood-brain barrier, invading the central nervous system 
and caused the neurological and endocrine disorder including confusion, sensory 
disorder and sleep abnormalities which gave the disease its name (Simarro et al., 
2008). In the absence of a treatment, the disease progresses to the final stage, leading 
to coma and death.  
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Figure 2.3: The Tsetse fly 
Image source: http://www.nri.org/news/archive/newsarchive2000-01.htm 
(accessed on Jan 18,2012) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
